In a recent study, compared with vehicle treatment, IL-37 (1μg/mouse) treatment of mice improves insulin sensitivity and ameliorates obesity-induced inflammation in adipose tissue after 22 weeks of high fat diet (24). Here, IL37 is linked to obesity disorder.